Sebahat Usta Akgul

Sebahat Usta Akgul

Auto-generated profile, based on publicly available information

Sebahat Usta Akgul

Transplant Immunology Research Center of Excellence Koç University Hospital Istanbul Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JXJingyuan Xie
Jingyuan Xie
LLLili Liu
Lili Liu
NMNikol Mladkova
Nikol Mladkova
YLYifu Li
Yifu Li
HRHong Ren
Hong Ren
KKKrzysztof Kiryluk
Krzysztof Kiryluk
Membranous Nephropathy (MN) is a rare autoimmune cause of kidney failure. Here we report a genome-wide association study (GWAS) for primary MN in 3,782 cases and 9,038 controls of East Asian and European ancestries. We discover two previously unreported loci, NFKB1 (rs230540, OR = 1.25, P = 3.4 × 10−12) and IRF4 (rs9405192, OR = 1.29, P = 1.4 × 10−14), fine-map the PLA2R1 locus (rs17831251, OR = 2.25, P = 4.7 × 10−103) and report ancestry-specific effects of three classical HLA alleles: DRB1*1501 in East Asians (OR = 3.81, P = 2.0 × 10−49), DQA1*0501 in Europeans (OR = 2.88, P = 5.7 × 10−93), and DRB1*0301 in both ethnicities (OR = 3.50, P = 9.2 × 10−23 and OR = 3.39, P = 5.2 × 10−82, respectively). GWAS loci explain 32% of disease risk in East Asians and 25% in Europeans, and correctly re-classify 20–37% of the cases in validation cohorts that are antibody-negative by the serum anti-PLA2R ELISA diagnostic test. Our findings highlight an unusual genetic architecture of MN, with four loci and their interactions accounting for nearly one-third of the disease risk.

28 October 2022 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
SASebahat Usta Akgul
Sebahat Usta Akgul
CCCigdem Kekik Cinar
Cigdem Kekik Cinar
YCYasar Caliskan
Yasar Caliskan
EDErol Demir
Erol Demir
ECEgemen Cebeci
Egemen Cebeci
FOFatma Savran Oguz
Fatma Savran Oguz

20 March 2019 in Clinical Science of Nutrition
Verified
Journal Article
Closed access
AAAysun Aksoy
Aysun Aksoy
TATimur Selçuk Akpınar
Timur Selçuk Akpınar
AYAlattin Yıldız
Alattin Yıldız
SASebahat Usta Akgül
Sebahat Usta Akgül
ETEge Sinan Torun
Ege Sinan Torun
BSBulent Saka
Bulent Saka
Objective: Patients with chronic kidney disease (CKD) are susceptible to systemic inflammation and nutritional disorders, which are associated with morbidity and mortality. The aim of the present study was to evaluate the relationship between nutritional status, lean body mass, physical activity, and systemic inflammation in patients with stage 3-5 non-dialysis-dependent CKD. Methods: A total of 55 predialysis patients with CKD were included in this cross-sectional study. Patients were divided into two groups according to the Subjective Global Assessment: 35 with normal nutritional status (NN) and 20 with malnutrition (MN). Anthropometric measurements, fat-free mass, muscle strength, physical activity, biochemical parameters, and serum cytokine levels of the patients were compared. Results: Patients with CKD and malnutrition (CKD-MN) had higher serum phosphate, interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-α levels and lower serum albumin levels and blood lymphocyte counts than those with CKD-NN independent from glomerular filtration rate. Regression analysis showed a relationship between MN and serum phosphate level, blood lymphocyte count, and serum IL-6 and TNF-α levels. Muscle strength and gait speed showed a positive relationship with nutritional status and negative relationship with inflammation. Conclusion: An increased inflammatory environment in patients with non-dialysis-dependent CKD was significantly associated with MN and decreased physical activity. An increased serum phosphate level appears to contribute to this MN-inflammation environment.

2 February 2024 in HLA
Verified
Journal Article
Open access
SASebahat Usta Akgul
Sebahat Usta Akgul
TCTalin Catalbasyan
Talin Catalbasyan
DDDemir Kaan Demir
Demir Kaan Demir
MBMahdis Borjkhani
Mahdis Borjkhani
CSCaner Süsal
Caner Süsal
HLA‐B*39:199 differs from HLA‐B*39:10:01 by a G → A substitution in exon 5 in codon 282.

15 April 2025 in Turkish Journal of Nephrology
Verified
Journal Article
Open access
ADAhmet Burak Dirim
Ahmet Burak Dirim
SMSafak Mirioglu
Safak Mirioglu
OOOzgur Akin Oto
Ozgur Akin Oto
AAAyse Serra Artan
Ayse Serra Artan
YOYasemin Ozluk
Yasemin Ozluk
YCYasar Caliskan
Yasar Caliskan
Background: IgA nephropathy (IgAN) recurrence a"er kidney transplantation (KTx) could cause allogra" loss. New bio markers are needed to assess the risk of IgAN recurrence and allogra" dysfunction following KTx. Methods: Thirty-seven KTx recipients who underwent KTx between 2002-2011 with biopsy-confirmed pre-transplant IgAN were evaluated in this retrospective study. Demographics, pathological and clinical/laboratory findings, and biomarkers, including levels of advanced oxidative protein products (AOPP) and galactose-deficient IgA1 and 4 tag single-nucleotide variants (tSNVs) associated with IgAN, were recorded. The primary outcome was IgAN recurrence. Biopsy-proven allogra" rejection (BPAR) and death-censored gra" failure (DCGF) were secondary outcomes. Results: 72.9% of patients were male. The mean age of KTx recipients was 37.4 ± 9.9 years. 45.9% of them experienced a recurrence of IgAN, during a median of 125 months of follow-up. There were more male donors in the recurrent IgAN group (P = .022). The median levels of UPCR were higher (P = .002) and estimated glomerular filtration rate (eGFR) were lower (P = .007) at the time of sampling in the recurrent group. Donor sex (male) (P = .018, HR: 3.853, 95% CI: 1.256-11.826) and eGFR at sampling (P = .039, HR: 0.967, 95% CI: 0.937-0.998) were predictors of IgAN recurrence in Cox regression analysis. Advanced oxidative protein products (median 78.4 vs 67.35 (#mol/L)) and Gd-IgA1 (median 5390.3 vs 4732.5 ng/#L) levels were insignificantly elevated in the patients with IgAN recurrence. Statistical di$erences were not present in terms of sec ondary outcomes between the patients with and without IgAN recurrence. Single-nucleotide variants were not statistically associated with the recurrence of IgAN. Conclusions: Prospective biomarker/genetic marker studies, including large patient cohorts, are required to evaluate the risk of IgAN recurrence and allogra" function a"er KTx. Cite this article as: Dirim AB, Mirioglu S, Oto OA, et!al. Prediction of recurrence and gra" outcomes in kidney transplant recipients with IgA nephropathy: role of genetic and oxidative stress markers. Turk J Nephrol. 2025;34(2):124-133.